Loading clinical trials...
Loading clinical trials...
Randomised Comparative Study Of Folfox6m Plus Sir-Spheres® Microspheres Versus Folfox6m Alone As First Line Treatment In Patients With Nonresectable Liver Metastases From Primary Colorectal Carcinoma
Conditions
Interventions
SIR-Spheres yttrium-90 microspheres
Systemic chemotherapy (FOLFOX)
Locations
111
United States
Pinnacle Oncology Hematology
Scottsdale, Arizona, United States
City of Hope Hospital
Duarte, California, United States
Florida International University College of Medicine Practice
North Miami Beach, Florida, United States
Vanguard Health
Berwyn, Illinois, United States
University of Illinois at Chicago
Chicago, Illinois, United States
Ingalls Memorial Hospital
Harvey, Illinois, United States
Start Date
August 1, 2006
Primary Completion Date
May 1, 2015
Completion Date
May 1, 2015
Last Updated
March 26, 2019
NCT07446322
NCT07541924
NCT05969860
NCT04693377
NCT07416552
NCT07529301
Lead Sponsor
Sirtex Medical
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions